Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by EndoHypoton Jan 14, 2021 7:45pm
211 Views
Post# 32303101

RE:RE:RE:RE:NY Post on COVID19 the gut and Cytokines (link below)

RE:RE:RE:RE:NY Post on COVID19 the gut and Cytokines (link below)The only questions are are...

Will the buyers that need a better HHD machine, decide to make a move on us, before all the "i's" are dotted and the"t's" are crossed with the FDA?

That's another big reason why a second suitor is necessary.  Firstly, they force price discovery to happen.  Secondly, they force the proposal to happen much sooner, out of fear of loss.

Or will Baxter make a move on the PMX/EAA based on Interim data (assuming it's as good as has been hinted at so far).  There may be some ethical dilemma's in finishing the Tigris Trial, as well ...depending how well its going (think Euphas 1) AND depending on how well the Covid-19 add on (separate) study is going (it's been VERY quiet).  Let's hope it's going as well as some of the Italian and Japanese Studies so far (meaning PMX might have a MUCH wider usage going forward).

You are very wise to point out this ethical dilemma.  If only 15% of the 2/3 PMX patients are dying, BUT 45% of the SOC patients are dying, can we really ethically deny these people from this truism?

So it's a question of which daughter gets married off to a handsome suitor first?  The nice thing is that both, are young & pretty, and come with a very nice & substantial dowery.

Careful, the woke people might raise an eyebrow at your analogy.  Though it's a really good analogy, we now live in a world where it's Amen, AND also, A-Women!

Speaking of ethical dilemma's maybe just the one suitor will take both daughter's hands in marriage !?!?

I thought you lived in Canada MM?  I didn't know you were a Utah boy.  Careful, or the wokeness might cancel you lol.

In any event, I agree.... I think this is the year that they both come of age.

Definitely.  Not going to talk about it, but I am of the opinion that home approval probably happens half a year ahead of schedule.

MM

<< Previous
Bullboard Posts
Next >>